Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-75.0%
0%
-75.0%
6 Months
-85.71%
0%
-85.71%
1 Year
-85.71%
0%
-85.71%
2 Years
-98.26%
0%
-98.26%
3 Years
-98.52%
0%
-98.52%
4 Years
-99.09%
0%
-99.09%
5 Years
-98.48%
0%
-98.48%
Deltex Medical Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-17.37%
EBIT Growth (5y)
-24.21%
EBIT to Interest (avg)
-0.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.55
Sales to Capital Employed (avg)
0.63
Tax Ratio
3.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.16
EV to EBIT
-2.02
EV to EBITDA
-2.03
EV to Capital Employed
0.46
EV to Sales
1.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.14%
ROE (Latest)
-32.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2021
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (5.53%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
1.80
2.50
-28.00%
Operating Profit (PBDIT) excl Other Income
-0.80
-0.90
11.11%
Interest
0.20
0.20
Exceptional Items
-0.30
0.00
Consolidate Net Profit
-1.30
-1.10
-18.18%
Operating Profit Margin (Excl OI)
-523.10%
-422.20%
-10.09%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -28.00% vs 8.70% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -18.18% vs -10.00% in Dec 2022
About Deltex Medical Group Plc 
Deltex Medical Group Plc
Medical Specialties
Deltex Medical Group plc is a United Kingdom-based haemodynamic management company, which manufactures fluid management devices. The Company's segments are Probes and Other. The Company's Esophageal Doppler Simulator (EDS) enables clinicians to practice probe insertion, focussing and waveform interpretation outside of a patient setting. The Company's CardioQ-EDM and CardioQ-EDM+ esophageal Doppler monitors (EDM) are designed to allow clinicians to guide fluid and drug administration during surgery. The Company's oesophageal Doppler haemodynamic monitoring (ODM) uses ultrasound to measure blood flows in the central circulation of patients, and allows doctors to fine tune the circulation. Its probes include surgical probes, such as I2S and I2P, and critical care probes, such as I2C and EDP240. Its I2S and I2P are used in patients who are anesthetized, sedated or awake. Its EDP240 is used in patients under anesthesia or full sedation. It has operations in Spain and Canada, among others.
Company Coordinates 
Company Details
Terminus Road , CHICHESTER None : PO19 8TX
Registrar Details






